Cancer Research · 2009 · 82 citations · 29 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionAngiogenesisAngiogenesis In CancerCancer ProgressionAngiogenesis In NeoplasmsBlood FlowHepatocellular Carcinoma MetastasisTransgenic MiceTransgenic Mouse Cancer ModelsTransgenic Mouse ModelsTumor Growth DynamicsTumor Growth Rate
Angiotensinogen, a member of the serpin family, is involved in the suppression of tumor growth and metastasis. To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice). Bitransgenic mice overexpressing human angiotensinogen (HCC/Hu-AGT-TG) had a significantly longer survival time than the HCC-TG mice and a reduction of both tumor growth and blood flow velocities in the liver. This antitumor effect of angiotensinogen is related to a reduced angiogenesis, impaired expression of endothelial arterial markers (active Notch4, Delta-like 4 ligand, and ephrin B2) with a decrease of arterial vessel density in HCC/Hu-AGT-TG mice liver. Overexpression of human angiotensinogen decreases angiogenesis, and prevents tumor sinusoids from remodeling and arterialization, thus delaying tumor progression in vivo.
29
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
David W. Dawson, Olga V. Volpert, Paul Gillis et al. · Science · 1999 · 1.5K citations
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera‐Troise, Christopher Daly, Nicholas Papadopoulos et al. · Nature · 2006 · 1K citations
Medicine, Cancer Biology, Oncology +14
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
John Brady Ridgway, Gu Zhang, Yan Wu et al. · Nature · 2006 · 982 citations
Medicine, Cancer Biology, Oncology +12